US4853221A
(en)
|
1980-11-13 |
1989-08-01 |
Warner-Lambert Company |
Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US5294430A
(en)
|
1988-09-12 |
1994-03-15 |
University Of Rochester |
Use of dithiocarbamates to treat myelosuppression
|
US5035878A
(en)
|
1988-09-12 |
1991-07-30 |
University Of Rochester |
Use of dithiocarbamates to counteract myelosuppression
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5597798A
(en)
|
1990-03-05 |
1997-01-28 |
The Regents Of The University Of California |
Taxol and epidermal growth factor used to enhance treatment of ovarian cancer
|
EP0572549B1
(en)
|
1991-02-21 |
2002-11-20 |
Smithkline Beecham Corporation |
Use of topotecan in the treatment of non-small cell lung carcinoma
|
US6287792B1
(en)
|
1991-06-17 |
2001-09-11 |
The Regents Of The University Of California |
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
|
US5795870A
(en)
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
KR970702725A
(ko)
|
1994-04-26 |
1997-06-10 |
노부히로 나리따 |
비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
WO1998055650A1
(en)
|
1997-06-04 |
1998-12-10 |
Rijksuniversiteit Te Leiden |
A diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination
|
US6335156B1
(en)
|
1997-12-18 |
2002-01-01 |
The Johns Hopkins University School Of Medicine |
14-3-3σ arrests the cell cycle
|
CA2319495A1
(en)
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
ATE315392T1
(de)
|
1998-07-09 |
2006-02-15 |
Francis A Nardella |
Zusammensetzungen zur behandlung chronischer lymphatischer leukämie
|
AU6607100A
(en)
|
1999-07-23 |
2001-02-13 |
Regents Of The University Of California, The |
Anti-growth factor receptor avidin fusion proteins as universal vectors for drugdelivery
|
US6635677B2
(en)
|
1999-08-13 |
2003-10-21 |
Case Western Reserve University |
Methoxyamine combinations in the treatment of cancer
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
US20020037328A1
(en)
*
|
2000-06-01 |
2002-03-28 |
Brown Dennis M. |
Hexitol compositions and uses thereof
|
GB0014820D0
(en)
|
2000-06-16 |
2000-08-09 |
Medical Res Council |
Methods and materials relating to plasmid vectors
|
ITMI20002358A1
(it)
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
WO2003000012A2
(en)
|
2001-06-21 |
2003-01-03 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
|
EP1585817B1
(en)
|
2002-02-20 |
2009-09-02 |
The General Hospital Corporation |
Conjugates comprising a biodegradable polymer and uses therefor
|
CA2477953A1
(en)
|
2002-03-01 |
2003-09-12 |
Roger Williams Hospital |
Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
|
AU2003223529A1
(en)
|
2002-04-11 |
2003-10-27 |
Zymogenetics, Inc. |
Use of interleukin-19 to treat ovarian cancer
|
CA2480176A1
(en)
|
2002-04-11 |
2003-10-23 |
Zymogenetics, Inc. |
Use of interleukin-24 to treat ovarian cancer
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US20060058217A1
(en)
|
2003-01-21 |
2006-03-16 |
White Hillary D |
Compositions and methods for treatment of ovarian cancer
|
NZ567952A
(en)
|
2003-03-24 |
2009-12-24 |
Sequoia Pharmaceuticals Inc |
Long acting biologically active conjugates
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
HUE059464T2
(hu)
|
2003-04-11 |
2022-11-28 |
Ptc Therapeutics Inc |
1,2,4-Oxadiazolbenzoesav-vegyületek és ezek alkalmazása nonsense szuppresszióhoz és betegségek kezelésére
|
EP1663202A1
(en)
|
2003-09-04 |
2006-06-07 |
Aventis Pharmaceuticals, Inc. |
Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
|
US7446122B2
(en)
|
2003-10-02 |
2008-11-04 |
Cephalon, Inc. |
Substituted indole derivatives
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
AU2004289539C1
(en)
|
2003-11-14 |
2012-06-07 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
JP4856623B2
(ja)
|
2004-03-11 |
2012-01-18 |
フォーエスシー アクチエンゲゼルシャフト |
新規のn−スルホニルピロール誘導体
|
WO2005099824A1
(en)
|
2004-03-30 |
2005-10-27 |
Synta Pharmaceuticals, Corp. |
1-glyoxylamide indolizines for treating lung and ovarian cancer
|
WO2005098446A2
(en)
|
2004-03-31 |
2005-10-20 |
The Johns Hopkins University |
Biomarkers for ovarian cancer
|
US8957056B2
(en)
|
2004-05-25 |
2015-02-17 |
Sloan-Kettering Instiute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
DE602005026391D1
(de)
|
2004-06-30 |
2011-03-31 |
Janssen Pharmaceutica Nv |
Chinazolinonderivate als parp-hemmer
|
EP1864998B2
(en)
|
2004-07-22 |
2022-06-22 |
Erasmus University Medical Center Rotterdam |
Binding molecules
|
AU2005277648B2
(en)
|
2004-08-20 |
2011-12-22 |
Buck Institute For Age Research |
Small molecules that replace or agonize p53 function
|
US8969379B2
(en)
|
2004-09-17 |
2015-03-03 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
CA2588389A1
(en)
|
2004-11-23 |
2006-06-22 |
Ptc Therapeutics, Inc. |
Substituted phenols as active agents inhibiting vegf production
|
DK1827437T3
(da)
|
2004-12-15 |
2012-02-13 |
Sigma Tau Ind Farmaceuti |
Kombinationer af terapeutiske midler til cancerbehandling
|
WO2006078711A2
(en)
|
2005-01-19 |
2006-07-27 |
Mgi Gp, Inc. |
Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp
|
US8404829B2
(en)
|
2005-01-25 |
2013-03-26 |
The Regents Of The University Of California |
Predictive and therapeutic markers in ovarian cancer
|
EP1702989A1
(en)
|
2005-03-16 |
2006-09-20 |
Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon |
Method of predicting the clinical response to cisplatin or carboplatin chemotherapeutic treatment
|
US7728026B2
(en)
|
2005-04-11 |
2010-06-01 |
Abbott Laboratories, Inc. |
2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
|
BRPI0608096A2
(pt)
|
2005-04-26 |
2009-11-10 |
Pfizer |
anticorpos p-caderina
|
AR053272A1
(es)
|
2005-05-11 |
2007-04-25 |
Hoffmann La Roche |
Determinacion de responsivos a la quimioterapia
|
BRPI0612138B8
(pt)
|
2005-06-15 |
2021-05-25 |
Cardiome Pharma Corp |
compostos éter aminocicloexílicos e método para fazer os mesmos
|
EP1910821B1
(en)
|
2005-06-24 |
2013-02-20 |
Ciphergen Biosystems, Inc. |
Biomarkers for ovarian cancer
|
EP1924568A1
(en)
*
|
2005-07-15 |
2008-05-28 |
Schering Corporation |
Quinazoline derivatives useful in cancer treatment
|
WO2007013946A2
(en)
|
2005-07-20 |
2007-02-01 |
University Of South Florida |
Method of predicting responsiveness to chemotherapy and selecting treatments
|
US8101799B2
(en)
|
2005-07-21 |
2012-01-24 |
Ardea Biosciences |
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
|
AU2006279794B2
(en)
|
2005-08-12 |
2011-04-07 |
Synta Pharmaceuticals Corp. |
Pyrazole compounds that modulate HSP90 activity
|
US7507536B2
(en)
|
2005-10-07 |
2009-03-24 |
The Johns Hopkins University |
Methylation markers for diagnosis and treatment of ovarian cancer
|
US8124095B2
(en)
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
EP1938823A1
(en)
|
2005-10-19 |
2008-07-02 |
Chugai Seiyaku Kabushiki Kaisha |
Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug
|
US20090099102A1
(en)
|
2005-10-27 |
2009-04-16 |
The Brigham And Women's Hospital, Inc. |
Ginkgolides in the Treatment and Prevention of Ovarian Cancer
|
CA2833706C
(en)
|
2005-11-11 |
2014-10-21 |
Boehringer Ingelheim International Gmbh |
Quinazoline derivatives for the treatment of cancer diseases
|
EP1951283B1
(en)
|
2005-11-16 |
2010-07-14 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for treating or preventing ovarian cancer
|
US8450351B2
(en)
|
2005-12-20 |
2013-05-28 |
Incyte Corporation |
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
|
WO2007070984A1
(en)
|
2005-12-23 |
2007-06-28 |
Ecobiotics Limited |
Spiroketals
|
EP1986625B1
(en)
|
2006-02-10 |
2012-08-01 |
Ramot at Tel-Aviv University Ltd. |
Treatment of ovarian cancer
|
KR101549364B1
(ko)
|
2006-03-17 |
2015-09-01 |
암비트 바이오사이언시즈 코포레이션 |
질환 치료용 이미다졸로티아졸 화합물
|
AR060631A1
(es)
|
2006-04-26 |
2008-07-02 |
Piramed Ltd |
Derivados de pirimidina y su uso como inhibidores de fosfatidilnositol 3-quinasa (pi3k)
|
IL282783B2
(en)
|
2006-05-18 |
2023-09-01 |
Caris Mpi Inc |
A system and method for determining a personalized medical intervention for a disease stage
|
US8768629B2
(en)
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
CA2653217A1
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
CA2653222A1
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
CA2655561C
(en)
|
2006-06-20 |
2014-10-21 |
Abbott Laboratories |
Pyrazoloquinazolinones as parp inhibitors
|
DK2061765T3
(en)
|
2006-09-01 |
2015-01-26 |
Senhwa Biosciences Inc |
Serine-threonine protein kinase AND PARP-MODULATOR
|
US7547781B2
(en)
|
2006-09-11 |
2009-06-16 |
Curis, Inc. |
Quinazoline based EGFR inhibitors containing a zinc binding moiety
|
JP5721949B2
(ja)
|
2006-10-12 |
2015-05-20 |
アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited |
複合薬剤
|
UY30639A1
(es)
|
2006-10-17 |
2008-05-31 |
Kudos Pharm Ltd |
Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
|
EP2815750A1
(en)
|
2006-12-21 |
2014-12-24 |
Vertex Pharmaceuticals Incorporated |
5-cyano-4-(pyrrolo [2,3b] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
WO2008098139A2
(en)
|
2007-02-07 |
2008-08-14 |
The Regents Of The University Of Colorado |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
PL2716301T3
(pl)
|
2007-02-16 |
2017-10-31 |
Merrimack Pharmaceuticals Inc |
Przeciwciała przeciw ERBB3 i ich zastosowania
|
CA2677046A1
(en)
|
2007-02-28 |
2008-09-04 |
Inotek Pharmaceuticals Corporation |
Indenoisoquinolinone analogs and methods of use thereof
|
WO2008109440A2
(en)
|
2007-03-02 |
2008-09-12 |
Genentech, Inc. |
Predicting response to a her dimerisation inhibitor based on low her3 expression
|
US8299256B2
(en)
|
2007-03-08 |
2012-10-30 |
Janssen Pharmaceutica Nv |
Quinolinone derivatives as PARP and TANK inhibitors
|
US8030060B2
(en)
|
2007-03-22 |
2011-10-04 |
West Virginia University |
Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer
|
AR065948A1
(es)
|
2007-04-06 |
2009-07-15 |
Neurocrine Biosciences Inc |
Antagonistas del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
JP2008295328A
(ja)
|
2007-05-30 |
2008-12-11 |
Fujifilm Corp |
卵巣癌の検出方法、及び抑制方法
|
CN101678019B
(zh)
|
2007-06-08 |
2016-03-30 |
詹森药业有限公司 |
哌啶/哌嗪衍生物
|
EP2637020A3
(en)
|
2007-06-29 |
2014-01-08 |
Correlogic Systems Inc. |
Predictive markers for ovarian cancer
|
WO2009016565A1
(en)
|
2007-07-27 |
2009-02-05 |
Piramal Life Sciences Limited |
Tricyclic compounds for the treatment of inflammatory disorders
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
AU2008287831B2
(en)
|
2007-08-10 |
2013-05-23 |
Mitsubishi Tanabe Pharma Corporation |
Novel salt of isoquinoline compound and crystal thereof
|
CN101802226A
(zh)
|
2007-09-17 |
2010-08-11 |
皇家飞利浦电子股份有限公司 |
分析卵巢癌病症的方法
|
RU2485122C2
(ru)
|
2007-10-03 |
2013-06-20 |
Эйсэй Инк. |
Соединения и композиции, ингибирующие parp, и способы их применения
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain vehicles, installations and methods
|
WO2009058102A1
(en)
|
2007-11-02 |
2009-05-07 |
Agency For Science, Technology And Research |
Methods and compounds for preventing and treating a tumour
|
IL187247A0
(en)
|
2007-11-08 |
2008-12-29 |
Hadasit Med Res Service |
Novel synthetic analogs of sphingolipids
|
EP2217244A4
(en)
|
2007-11-12 |
2011-08-31 |
Bipar Sciences Inc |
TREATMENT OF NUTRITIONAL CANCER AND EGG CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTITUMOROUS MEDICINES
|
US20090170842A1
(en)
|
2007-11-14 |
2009-07-02 |
University Of Kansas |
Brca1-based breast or ovarian cancer prevention agents and methods of use
|
RU2490265C2
(ru)
|
2007-11-15 |
2013-08-20 |
Институто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти С.П.А. |
Пиридазиноновые производные в качестве ингибиторов parp
|
WO2009065230A1
(en)
|
2007-11-23 |
2009-05-28 |
British Columbia Cancer Agency Branch |
Methods for detecting lung cancer and monitoring treatment response
|
US8476420B2
(en)
|
2007-12-05 |
2013-07-02 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
WO2009071660A1
(en)
|
2007-12-06 |
2009-06-11 |
Novartis Forschungsstiftung, Zweigniederlassung |
Use of protease nexin 1 inhibitors to reduce metastasis
|
US8741889B2
(en)
|
2008-01-11 |
2014-06-03 |
Hoffmann-La Roche Inc |
Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor
|
WO2009097446A1
(en)
|
2008-01-30 |
2009-08-06 |
Genentech, Inc. |
Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
|
WO2009099561A2
(en)
|
2008-01-31 |
2009-08-13 |
The Brigham And Womens' Hospital, Inc. |
Urinary ca125 peptides as biomarkers of ovarian cancer
|
CN101998959B
(zh)
|
2008-02-06 |
2013-08-28 |
生物马林药物股份有限公司 |
聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂
|
CN104474529A
(zh)
|
2008-02-08 |
2015-04-01 |
爱勒让治疗公司 |
治疗性的拟肽大环化合物
|
US8828657B2
(en)
|
2008-02-14 |
2014-09-09 |
Decode Genetics Ehf. |
Susceptibility variants for lung cancer
|
US8541433B2
(en)
|
2008-02-20 |
2013-09-24 |
Actelion Pharmaceuticals, Ltd. |
Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer
|
FR2928151B1
(fr)
|
2008-03-03 |
2010-12-31 |
Sanofi Aventis |
Derives platine-carbene n-heterocyclique, leur preparation et leur application en therapeutique
|
MX2010010172A
(es)
|
2008-03-17 |
2010-11-25 |
Ambit Biosciences Corp |
Derivados de quinazolina como moduladores de quinasa raf y metodos de uso de los mismos.
|
US8476026B2
(en)
|
2008-04-01 |
2013-07-02 |
The Brigham And Women's Hospital, Inc. |
Biomarkers of ovarian cancer
|
MX2010011258A
(es)
|
2008-04-14 |
2011-06-20 |
Univ Texas |
Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos.
|
ES2584932T3
(es)
|
2008-04-16 |
2016-09-30 |
Assistance Publique Hôpitaux De Paris |
Métodos para el tratamiento, la evaluación pronóstica y la estadificación de cáncer no microcítico de pulmón
|
CL2009001152A1
(es)
|
2008-05-13 |
2009-10-16 |
Array Biopharma Inc |
Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
|
JP5583117B2
(ja)
|
2008-05-14 |
2014-09-03 |
ユニバーシティー ヘルス ネットワーク |
非小細胞肺癌およびアジュバント化学療法に関する予後診断的および予測的な遺伝子シグネチャー
|
CA2725754C
(en)
|
2008-06-11 |
2017-05-23 |
Hazel Joan Dyke |
Diazacarbazoles and methods of use
|
ES2399319T3
(es)
|
2008-07-09 |
2013-03-27 |
Rigel Pharmaceuticals, Inc. |
Triazoles sustituidos con heteroarilos bicíclicos que contienen puentes útiles como inhibidores de AXL
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
WO2010006292A1
(en)
|
2008-07-11 |
2010-01-14 |
Neumedics |
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
|
SG193842A1
(en)
|
2008-08-06 |
2013-10-30 |
Biomarin Pharm Inc |
Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
|
WO2010017545A2
(en)
|
2008-08-08 |
2010-02-11 |
Synta Pharamceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
EA022884B1
(ru)
|
2008-08-15 |
2016-03-31 |
Мерримак Фармасьютикалз, Инк. |
СПОСОБ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ С ИСПОЛЬЗОВАНИЕМ АНТИ-ErbB3 АНТИТЕЛА
|
WO2010020675A1
(en)
|
2008-08-22 |
2010-02-25 |
Novartis Ag |
Pyrrolopyrimidine compounds as cdk inhibitors
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
KR100961410B1
(ko)
|
2008-10-14 |
2010-06-09 |
(주)네오팜 |
단백질 키나제 억제제로서 헤테로사이클릭 화합물
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
WO2010048330A1
(en)
|
2008-10-21 |
2010-04-29 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer using hypoxia activated prodrugs
|
US8946289B2
(en)
|
2008-11-19 |
2015-02-03 |
Duke University |
Manassatin compounds and methods of making and using the same
|
MX2011005526A
(es)
|
2008-11-26 |
2011-06-06 |
Pfizer |
3-aminociclopentancarboxamidas como moduladores de receptores de quimiocina.
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8058075B2
(en)
|
2008-12-10 |
2011-11-15 |
University Of Utah Research Foundation |
Molecular fluorescence sensor for highly sensitive and selective detection of mercury
|
ES2490613T3
(es)
|
2008-12-22 |
2014-09-04 |
F. Hoffmann-La Roche Ag |
ARMET como marcador de cáncer
|
SG172958A1
(en)
|
2009-01-23 |
2011-08-29 |
Takeda Pharmaceutical |
Poly (adp-ribose) polymerase (parp) inhibitors
|
CA2789365A1
(en)
|
2009-02-10 |
2010-08-19 |
Celgene International Sarl |
Methods for treating non-small cell lung cancer using 5-azacytidine
|
US8648046B2
(en)
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
MY159327A
(en)
|
2009-02-27 |
2016-12-25 |
Ambit Biosciences Corp |
Jak kinase modulating quinazoline derivatives and methods of use thereof
|
US8969001B2
(en)
|
2009-03-12 |
2015-03-03 |
Rush University Medical Center |
Materials and methods for predicting recurrence of non-small cell lung cancer
|
CN101869558A
(zh)
*
|
2009-04-22 |
2010-10-27 |
北京大学 |
二乙酰二脱水卫矛醇的抗血管生成及肿瘤转移作用
|
PT104607B
(pt)
|
2009-05-20 |
2012-03-23 |
Univ De Coimbra |
Derivados triterpenóides úteis como agentes antiproliferativos
|
EP3045457B1
(en)
|
2009-06-15 |
2018-05-09 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
|
US8980268B2
(en)
|
2009-07-29 |
2015-03-17 |
Regeneron Pharamceuticals, Inc. |
Methods for treating cancer by administering an anti-Ang-2 antibody
|
WO2011014681A1
(en)
|
2009-07-30 |
2011-02-03 |
Takeda Pharmaceutical Company Limited |
Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
|
EP2460005A4
(en)
|
2009-07-31 |
2012-11-21 |
Translational Genomics Res Inst |
METHOD FOR ASSESSING A CANCER PROGRESSION RISK
|
WO2011024873A1
(ja)
|
2009-08-26 |
2011-03-03 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
US20130203861A1
(en)
|
2009-09-09 |
2013-08-08 |
Golden Biotechnology Corporation |
Methods and compositions for treating ovarian cancer
|
US20120183546A1
(en)
|
2009-09-23 |
2012-07-19 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
ES2558742T3
(es)
|
2009-09-28 |
2016-02-08 |
F. Hoffmann-La Roche Ag |
Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
|
MX2012004064A
(es)
|
2009-10-08 |
2012-06-08 |
Sanford Burnham Med Res Inst |
Derivados apogosipolona como agentes antineoplasicos.
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
WO2011088192A1
(en)
|
2010-01-13 |
2011-07-21 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
JP5972176B2
(ja)
|
2010-02-23 |
2016-08-17 |
サノフイ |
抗アルファ2インテグリン抗体及びそれらの使用
|
EP2548017A2
(en)
|
2010-03-15 |
2013-01-23 |
Genus Oncology, Llc |
Small molecule inhibitors of muc1 and methods of identifying the same
|
EP2403855B1
(en)
|
2010-03-22 |
2013-05-01 |
Council of Scientific & Industrial Research |
Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
|
PL2563803T3
(pl)
|
2010-04-27 |
2016-08-31 |
Pharma Mar Sa |
Przeciwnowotworowe laktony steroidowe nienasycone w pozycji 7(8)
|
US8980933B2
(en)
|
2010-05-05 |
2015-03-17 |
Universitat Bayreuth |
Combretastatin analogs for use in the treatment of cancer
|
CN103003424B
(zh)
|
2010-05-18 |
2015-05-13 |
株式会社医学生物学研究所 |
结合转化生长因子α且对Ras基因突变的癌具有增殖抑制活性的抗体
|
MX365251B
(es)
|
2010-05-20 |
2019-05-28 |
Array Biopharma Inc |
Compuestos macrocíclicos como inhibidores de trk cinasa.
|
BR112012033253A2
(pt)
|
2010-06-23 |
2016-11-22 |
Hanmi Science Co Ltd |
novos derivados de pirimidina fundidos para inibição da atividade de tirosina quinase
|
WO2012006563A2
(en)
|
2010-07-08 |
2012-01-12 |
The Administrators Of The Tulane Educational Fund |
Novel daidzein analogs as treatment for cancer
|
ES2552841T3
(es)
|
2010-07-12 |
2015-12-02 |
Bayer Intellectual Property Gmbh |
Imidazo[1,2-a]pirimidinas y -piridinas sustituidas
|
GB201012105D0
(en)
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
US20120171694A1
(en)
|
2010-07-30 |
2012-07-05 |
Vermillion, Inc. |
Predictive markers and biomarker panels for ovarian cancer
|
JP5512894B2
(ja)
|
2010-08-05 |
2014-06-04 |
テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション |
2−置換−8−アルキル−7−オキソ−7,8−ジヒドロピリド[2,3d]ピリミジン−6−カルボニトリル及びその使用
|
CN103476250A
(zh)
*
|
2010-08-18 |
2013-12-25 |
德玛医药 |
改善未达最佳给药的化合物包括取代的己糖醇比如卫康醇与二乙酰二脱水卫矛醇的治疗效果的组合物和方法
|
WO2012027564A1
(en)
|
2010-08-26 |
2012-03-01 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
JP5842004B2
(ja)
|
2010-09-01 |
2016-01-13 |
ジーアイリード コネチカット インコーポレーテッドGilead Connecticut,Inc. |
ピリダジノン、その製造方法及びその使用方法
|
US8946216B2
(en)
|
2010-09-01 |
2015-02-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as ERK inhibitors
|
US8575191B2
(en)
|
2010-09-01 |
2013-11-05 |
Arqule, Inc. |
Methods for treatment of non-small cell lung cancer
|
WO2012037573A1
(en)
|
2010-09-17 |
2012-03-22 |
Indiana University Research And Technology Corporation |
Small molecule inhibitors of replication protein a that also act synergistically with cisplatin
|
US8927562B2
(en)
|
2010-09-28 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
KR101497113B1
(ko)
|
2010-10-20 |
2015-03-03 |
한국생명공학연구원 |
Hif-1 활성을 저해하는 아릴옥시페녹시아크릴계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
BR112013009531A2
(pt)
|
2010-11-11 |
2016-07-19 |
Redx Pharma Ltd |
derivados de fármaco
|
CN103403552B
(zh)
|
2010-11-12 |
2016-01-06 |
恩多塞特公司 |
治疗癌症的方法
|
AR083916A1
(es)
|
2010-11-18 |
2013-04-10 |
Takeda Pharmaceutical |
Metodo para tratar el cancer de mama y cancer de ovarios
|
EP2646430B1
(en)
|
2010-12-03 |
2016-09-21 |
Emory University |
Chemokine cxcr4 receptor modulators and uses related thereto
|
WO2012076942A1
(en)
|
2010-12-06 |
2012-06-14 |
Council Of Scientific & Industrial Research |
4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
|
AR084312A1
(es)
|
2010-12-16 |
2013-05-08 |
Genentech Inc |
Compuestos triciclicos inhibidores de la pi3k y composiciones farmaceuticas
|
KR20140022786A
(ko)
|
2010-12-17 |
2014-02-25 |
데스 알 리처드슨 |
티오세미카르바존 화합물 및 암 치료 용도
|
WO2012096832A2
(en)
|
2011-01-12 |
2012-07-19 |
Crystal Biopharmaceutical Llc |
Hdac inhibiting derivatives of camptothecin
|
CN103339134B
(zh)
|
2011-01-26 |
2015-12-23 |
内尔维阿诺医学科学有限公司 |
三环吡咯并衍生物、它们的制备方法和它们作为激酶抑制剂的应用
|
WO2012103456A2
(en)
|
2011-01-27 |
2012-08-02 |
Board Of Regents, The University Of Texas System |
Polycyclic beta lactam derivatives for the treatment of cancer
|
AP2013007043A0
(en)
|
2011-01-31 |
2013-08-31 |
Novartis Ag |
Novel heterocyclic derivatives
|
WO2012116328A2
(en)
|
2011-02-24 |
2012-08-30 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
|
WO2012115820A2
(en)
|
2011-02-24 |
2012-08-30 |
Vermillion, Inc. |
Biomarker panels, diagnostic methods and test kits for ovarian cancer
|
RU2598849C2
(ru)
|
2011-02-24 |
2016-09-27 |
Цзянсу Хэнсох Фармасьютикал Ко., Лтд. |
Содержащие фосфор соединения в качестве ингибиторов протеинкина3
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
SG192841A1
(en)
|
2011-03-01 |
2013-09-30 |
Nucana Biomed Ltd |
Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
|
WO2012119113A2
(en)
|
2011-03-02 |
2012-09-07 |
Nestec Sa |
Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures
|
US8987412B2
(en)
|
2011-03-04 |
2015-03-24 |
New York University |
Hydrogen bond surrogate macrocycles as modulators of Ras
|
US8748470B2
(en)
|
2011-03-17 |
2014-06-10 |
The University Of Chicago |
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins
|
US20140357605A1
(en)
|
2012-03-22 |
2014-12-04 |
Bristol-Myers Squibb Company |
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
|
US20120269827A1
(en)
|
2011-04-01 |
2012-10-25 |
Immunogen, Inc. |
Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube Cancer
|
WO2012138678A1
(en)
|
2011-04-04 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
Gamma secretase inhibitors
|
JP6046710B2
(ja)
|
2011-06-24 |
2016-12-21 |
アーキュール,インコーポレイティド |
置換されたイミダゾピリジニル−アミノピリジン化合物
|
CA2881993C
(en)
|
2011-07-27 |
2017-05-09 |
Astrazeneca Ab |
Substituted 4-methoxy-n3-(pyrimidin-2-yl)benzene-1,3-diamine compounds, and salts thereof
|
US9499530B2
(en)
|
2011-08-01 |
2016-11-22 |
Hangzhou Minsheng Institutes For Pharma Research |
Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
|
EP2739618B1
(en)
|
2011-08-04 |
2015-09-16 |
Array Biopharma, Inc. |
Quinazoline compounds as serine/threonine kinase inhibitors
|
US9045450B2
(en)
|
2011-08-10 |
2015-06-02 |
Zhen Yang |
Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer
|
DE102011112978A1
(de)
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
EA023171B1
(ru)
|
2011-09-19 |
2016-04-29 |
Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. |
Тиопроизводные лактамов в качестве высокоактивных ингибиторов hdac и их применение в качестве лекарственных средств
|
WO2013043255A1
(en)
|
2011-09-21 |
2013-03-28 |
University Of South Alabama |
Methods and compositions for the treatment of ovarian cancer
|
WO2013041042A1
(en)
|
2011-09-22 |
2013-03-28 |
Merck Sharp & Dohme Corp. |
Pyrazole carboxamides as janus kinase inhibitors
|
PE20141581A1
(es)
|
2011-09-27 |
2014-11-14 |
Novartis Ag |
3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
|
HUE031445T2
(en)
|
2011-09-28 |
2017-07-28 |
Euro Celtique Sa |
Nitrogen mustard derivatives
|
CN104039797B
(zh)
|
2011-10-12 |
2016-06-01 |
南京奥昭生物科技有限公司 |
作为细胞凋亡诱导剂的杂环分子
|
CN103958508B
(zh)
|
2011-10-14 |
2019-02-12 |
艾伯维公司 |
用于治疗癌症以及免疫与自身免疫性疾病的细胞凋亡诱导剂
|
US20140357594A1
(en)
|
2011-10-24 |
2014-12-04 |
Glaxosmithkline Intellectual Property (No.2) Limited |
New compounds
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
BR112014010699B1
(pt)
|
2011-11-03 |
2020-12-15 |
Millennium Pharmaceuticals, Inc |
Uso de um inibidor nae com um agente de hipometilação para tratar malignidade hematológica e kit
|
PE20141686A1
(es)
|
2011-11-03 |
2014-11-08 |
Hoffmann La Roche |
Compuestos de piperazina alquilados como inhibidores de actividad btk
|
JP2015501792A
(ja)
|
2011-11-10 |
2015-01-19 |
メモリアル スローン−ケタリング キャンサー センター |
ベンジリデンベンゾヒドラジドを用いた卵巣がんの治療
|
CN104185631A
(zh)
|
2011-11-10 |
2014-12-03 |
纪念斯隆-凯特琳癌症中心 |
用2-氨基-4H-萘并[1,2-b]吡喃-3-甲腈治疗卵巢癌
|
US9844529B2
(en)
|
2011-11-11 |
2017-12-19 |
Eli Lilly And Company |
Combination therapy for ovarian cancer
|
BR112014012407A2
(pt)
|
2011-11-22 |
2017-06-06 |
Deciphera Pharmaceuticals Llc |
amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativas
|
CN104066435A
(zh)
|
2011-12-21 |
2014-09-24 |
纽约大学 |
蛋白水解抗性的氢键替代螺旋
|
CN104066735B
(zh)
|
2012-01-10 |
2016-08-31 |
拜耳知识产权有限责任公司 |
作为akt激酶抑制剂的取代的咪唑并吡嗪
|
EP2804850B1
(en)
|
2012-01-19 |
2018-08-29 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
MX367614B
(es)
*
|
2012-01-20 |
2019-08-28 |
Del Mar Pharmaceuticals |
Uso de hexitoles sustituidos que incluyen dianhidrogalactitol y analogos para tratar enfermedad neoplasica y celulas madre de cancer que incluyen glioblastoma multiforme y meduloblastoma.
|
PL2810937T3
(pl)
|
2012-01-31 |
2017-07-31 |
Daiichi Sankyo Company, Limited |
Pochodna pirydonu
|
AR092790A1
(es)
|
2012-02-01 |
2015-05-06 |
Euro Celtique Sa |
Derivados bencimidazolicos del acido hidroxamico
|
SG10201507865QA
(en)
|
2012-03-06 |
2015-10-29 |
Cephalon Inc |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
|
US9266828B2
(en)
|
2012-03-16 |
2016-02-23 |
Sanford-Burnham Medical Research Institute |
Inhibitors of Furin and other pro-protein convertases
|
MX359770B
(es)
|
2012-03-20 |
2018-10-10 |
Novartis Ag Star |
Terapia de combinacion de un inhibidor de mek e inhibidor de igf1r.
|
CA2865719C
(en)
|
2012-03-30 |
2020-09-22 |
Rhizen Pharmaceuticals Sa |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases
|
US10280168B2
(en)
|
2012-03-30 |
2019-05-07 |
Agency For Science, Technology And Research |
Bicyclic heteroaryl derivatives as MNK1 and MNK2 modulators and uses thereof
|
US9809858B2
(en)
|
2012-04-05 |
2017-11-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
O-glycan pathway ovarian cancer signature
|
EP2836482B1
(en)
|
2012-04-10 |
2019-12-25 |
The Regents of The University of California |
Compositions and methods for treating cancer
|
CA2873097A1
(en)
|
2012-05-11 |
2013-11-14 |
Todd M. Hansen |
Pyridazine and pyridine derivatives as nampt inhibitors
|
WO2013181462A1
(en)
|
2012-05-31 |
2013-12-05 |
Amgen Inc. |
Use of amg 900 for the treatment of cancer
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US8980934B2
(en)
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
CN104797267A
(zh)
*
|
2012-06-26 |
2015-07-22 |
德玛医药 |
使用卫康醇、二乙酰二脱水卫矛醇、二溴卫矛醇或类似物或其衍生物治疗具有基因多型性或ahi1失调或突变患者的抗酪氨酸激酶抑制剂的恶性肿瘤的方法
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
WO2014078295A1
(en)
|
2012-11-13 |
2014-05-22 |
BoYen Therapeutics, Inc. |
Gemcitabine prodrugs and uses thereof
|
TW201438736A
(zh)
|
2012-11-14 |
2014-10-16 |
Regeneron Pharma |
以dll4拮抗劑治療卵巢癌之方法
|
US8946246B2
(en)
|
2012-11-16 |
2015-02-03 |
New Mexico Technical Research Foundation |
Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
|
US8987461B2
(en)
|
2012-12-06 |
2015-03-24 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
RU2690663C2
(ru)
|
2012-12-20 |
2019-06-05 |
Мерк Шарп И Доум Корп. |
Замещенные имидазопиридины в качестве ингибиторов hdm2
|
WO2014100818A1
(en)
|
2012-12-21 |
2014-06-26 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
US8940726B2
(en)
|
2012-12-21 |
2015-01-27 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
RS56169B1
(sr)
|
2013-02-14 |
2017-11-30 |
Bristol Myers Squibb Co |
Jedinjenja tubulisina, metode pripreme i primena
|
MX2015012158A
(es)
|
2013-03-11 |
2015-12-01 |
Abbvie Inc |
Inhibidores de bomodominio tetraciclicos fusionados.
|
AU2014244263A1
(en)
|
2013-03-13 |
2015-08-13 |
Abbvie Inc. |
CDK9 kinase inhibitors
|
JP2016512816A
(ja)
|
2013-03-15 |
2016-05-09 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Atrキナーゼの阻害剤として有用な化合物
|
EP2970289A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
US10413538B2
(en)
|
2013-05-08 |
2019-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer
|
US20140371158A1
(en)
|
2013-06-14 |
2014-12-18 |
Georgia Regents University |
Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway
|
AU2014100435A4
(en)
|
2013-06-17 |
2014-05-29 |
Macau University Of Science And Technology |
A novel treatment of Gefitinib-resistant non-small-cell lung cancer
|
KR101815360B1
(ko)
|
2013-07-03 |
2018-01-04 |
에프. 호프만-라 로슈 아게 |
헤테로아릴 피리돈 및 아자-피리돈 아마이드 화합물
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
US9278978B2
(en)
|
2013-08-23 |
2016-03-08 |
Boehringer Ingelheim International Gmbh |
6-Alkynyl Pyridine
|
US9249151B2
(en)
|
2013-08-23 |
2016-02-02 |
Boehringer Ingelheim International Gmbh |
Bis-amido pyridines
|
US20150065526A1
(en)
|
2013-09-05 |
2015-03-05 |
Emory University |
Overcoming acquired resistance to chemotherapy treatments through suppression of stat3
|
US8927717B1
(en)
|
2014-02-14 |
2015-01-06 |
National Defense Medical Center |
Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
|